| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 13 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials | |
| #5 | Measuring microorganism processes | |
| #6 | Microorganisms | |
| #7 | Animal care |
| # | Name | Total Patents |
|---|---|---|
| #1 | Mallat Ziad | 13 |
| #2 | Tedgui Alain | 10 |
| #3 | Tedder Thomas | 4 |
| #4 | Ait-Oufella Hafid | 4 |
| #5 | Danchin Nicolas | 3 |
| #6 | Simon Tabassome | 2 |
| #7 | Tsimikas Sotirios | 2 |
| #8 | Simon Tabasomme | 1 |
| #9 | Taleb Soraya | 1 |
| #10 | Freyssienet Jean-Marie | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2014004540A1 | Methods and kits for predicting the risk of having a cardiovascular event in a subject | |
| US2012311728A1 | Methods and pharmaceutical composition for the treatment of atherosclerosis | |
| US2012225427A1 | sPLA2 IIA Polymorphism Analysis for the Diagnosis/Prognosis of a Cardiovascular Disease/Event | |
| US2012076754A1 | Use of IL-17 Polypeptides for Use in the Prevention or Treatment of Atherosclerosis | |
| US2012264146A1 | Combination of spla2 activity and lp(a) cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event |